Skip to main content
Logo

Funding

We have demonstrated that sustained investment in African science holds the potential for strong and long-term impact. We fund game changing ideas and innovations to transform Africa

Funding Opportunities.

6 opportunities available

Deadline:

The AAS Affiliates live out the Academy’s vision of transforming lives through sciences in their research and leadership excellence. They actively contribute to the programme activities while also motivating other young researchers to pursue scientific excellence.

Deadline:

The first cohort of eight drug discovery scientists was successfully awarded, in June 2019, after a rigorous selection process. This is therefore an invitation to be part of the second next phase of support for the drug discovery call 2020.

Deadline:

Eligible innovators can apply for this competitive follow-on transition to scale or scale up grant which will run for a term of up to thirty-six (36) months. We will fund an amount which is commensurate with the scope of work proposed.

Deadline:

Global Effort on COVID-19 (GECO) Health Research is a new cross UK government funding call aiming to support applied health research that will address COVID-19 knowledge gaps. The focus is on understanding the pandemic and mitigating its health impacts in low and middle-income countries (LMIC) contexts. The call prioritises epidemiology, clinical management, infection control and health system responses.

Deadline:

Proposals are invited for short-term projects addressing and mitigating the health, social, economic, cultural and environmental impacts of the COVID-19 outbreak in Low and Middle Income Countries1.

Deadline:

Type of call: Rolling call

Currently, this call for applications can only be accessed by persons already holding a grant or a sub-grant in the DELTAS Africa, Grand Challenges Africa, H3Africa, FLAIR or any other programme of the AAS. 

Other Funding Opportunities

2 opportunities available

Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed)

Award value – N/A

Deadline – 

The purpose of this Funding Opportunity Announcement (FOA) is to provide an expedited funding mechanism for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NIAID is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19).

Link -  Read More

Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed)

Award value – N/A

Deadline – 

The purpose of this Funding Opportunity Announcement (FOA) is to provide an expedited funding mechanism for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NIAID is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19).

Link -  Read More